Jump to main content
Jump to site search


A nuclear permeable Ru(II)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies

Author affiliations

Abstract

Ru(II) polypyridyl complexes which can undergo photo-induced ligand dissociation and DNA covalent binding are considered as potential photoactivated chemotherapeutic (PACT) agents. Herein four pyridine-2-sulfonate (py-SO3) ligand based Ru(II) complexes [Ru(N-N)2(py-SO3)]+ (1–4) were synthesized and studied. All the complexes can undergo fast py-SO3 ligand dissociation and DNA covalent binding upon visible light irradiation. However, only complex 4 exhibited high photo-induced anticancer activities towards a series of cancer cells, with half maximal inhibitory concentration (IC50) values in 100–300 nM regions and phototoxicity index (PI) values of about 100. In particular, complex 4 can also kill cisplatin resistant SKOV-3 and A549 cancer cells with IC50 values in 200–400 nM regions and PI values of about 50, which should be the first report of Ru(II) based PACT agents that are also effective towards cisplatin resistant cancer cells. Complex 4 exhibited much higher cell uptake and nuclear accumulation levels, which may be the main reasons for its high anticancer activities. The in vivo anticancer experiments indicated that complex 4 can inhibit tumor growth significantly with fewer side effects. Our results may provide guidelines for developing novel photoactivatable Ru(II) anticancer agents.

Graphical abstract: A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies

Back to tab navigation

Supplementary files

Publication details

The article was received on 30 Jan 2019, accepted on 04 Apr 2019 and first published on 04 Apr 2019


Article type: Paper
DOI: 10.1039/C9DT00441F
Citation: Dalton Trans., 2019, Advance Article

  •   Request permissions

    A nuclear permeable Ru(II)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies

    N. Tian, Y. Feng, W. Sun, J. Lu, S. Lu, Y. Yao, C. Li, X. Wang and Q. Zhou, Dalton Trans., 2019, Advance Article , DOI: 10.1039/C9DT00441F

Search articles by author

Spotlight

Advertisements